4 terminated. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 3 | 2 | Terminated 2 |
Follow Telangiectasis: new trials by email Literature Review of Telangiectasis trials Research Report on Telangiectasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) IB1001 - Ataxia Telangiectasia | Phase 2 | Terminated | IntraBio Inc | 17 | 2020-01-08 | 2026-03-25 |
| Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia Pazopanib, Placebo - Telangiectasia, Hereditary Hemorrhagic | Phase 2 | Terminated | GlaxoSmithKline | 7 | 2015-02-25 | 2017-07-06 |
| Exparel as a Nerve Block for Severe Hand Pain liposomal bupivacaine - CREST Syndrome, Peripheral Vascular Disease | Phase 2 / Phase 3 | Terminated | Jose Soberon, MD | 13 | 2014-11-01 | 2024-05-21 |
| Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Bevacizumab, placebo - Hereditary Hemorrhagic Telangiectasia, Epistaxis | Phase 2 / Phase 3 | Terminated | Hospices Civils de Lyon | 80 | 2014-04-01 | 2015-11-20 |
Telangiectasia, Hereditary Hemorrhagic (2) · Ataxia Telangiectasia (1) · CREST Syndrome (1) · Epistaxis (1) · Hemorrhage (1) · Peripheral Vascular Diseases (1) · Raynaud Disease (1) · Scleroderma, Diffuse (1)
Cardiovascular Diseases (4) · Vascular Diseases (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Cardiovascular Abnormalities (2) · Congenital Abnormalities (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Malformations (2)
Bevacizumab (1) · IB1001 (1) · acetylleucine (1) · pazopanib (1)
GlaxoSmithKline (1) · Hospices Civils de Lyon (1) · IntraBio Inc (1) · Jose Soberon, MD (1)
United States (3) · Canada (1) · France (1) · Germany (1) · Spain (1) · United Kingdom (1)
Jose Soberon, MD (1)
PMID 27599328, PMID 33482890, PMID 34349180, PMID 34620022, PMID 40739200